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Naive CD4+ T cells differentiate into specific effector subsets—Th1, Th2, Th17, and T follicular helper (Tfh)—that provide immu-
nity against pathogen infection. The signaling pathways involved in generating these effector cells are partially known. However, 
the effects of mutations underlying human primary immunodeficiencies on these processes, and how they compromise specific 
immune responses, remain unresolved. By studying individuals with mutations in key signaling pathways, we identified nonredun-
dant pathways regulating human CD4+ T cell differentiation in vitro. IL12Rβ1/TYK2 and IFN-γR/STAT1 function in a feed-forward 
loop to induce Th1 cells, whereas IL-21/IL-21R/STAT3 signaling is required for Th17, Tfh, and IL-10–secreting cells. IL12Rβ1/
TYK2 and NEMO are also required for Th17 induction. Strikingly, gain-of-function STAT1 mutations recapitulated the impact of 
dominant-negative STAT3 mutations on Tfh and Th17 cells, revealing a putative inhibitory effect of hypermorphic STAT1 over 
STAT3. These findings provide mechanistic insight into the requirements for human T cell effector function, and explain clinical 
manifestations of these immunodeficient conditions. Furthermore, they identify molecules that could be targeted to modulate 
CD4+ T cell effector function in the settings of infection, vaccination, or immune dysregulation.
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Naive CD4+ T cells from humans and mice differentiate into 
distinct populations of effector cells with specialized functions. 
CD4+ T cell differentiation is mediated by the microenviron‑
ment in which the cells encounter and integrate various sig‑
nals provided by APCs in the form of MHC class II–peptide 
complexes, and co‑stimulatory signals provided by interacting 
surface receptors, cytokines, and associated signaling pathways 
and transcription factors. Thus, the generation of Th1 cells 
is driven by IL‑12 and IFN‑γ, which activate STAT4 and 
STAT1, respectively, to induce T‑bet and promote IFN‑γ pro‑
duction. Similarly, IL‑4 activates STAT6 to induce GATA3 
and cMaf to imprint a Th2 fate on naive CD4+ T cells. Th17 
cells require TGFβ, IL‑6, and IL‑23, which, through STAT3 
and RORγt, induce the signature Th17 cytokines IL‑17A, 
IL‑17F, and IL‑22 (O’Shea and Paul, 2010; Zhu and Paul, 
2010; Deenick et al., 2011; Zielinski et al., 2011; Vahedi et 
al., 2013). There also exists a population of effector CD4+ T 
cells that shares features of both Th1 and Th17 cells (termed 
Th1* or Th1/17 cells), insomuch that they produce IFN‑γ, 
IL‑17, and IL‑22, express RORγt and T‑bet, and coexpress 
the chemokine receptors CXCR3 and CCR6, which typi‑
cally define Th1 and Th17 cells, respectively (Annunziato et 
al., 2007; Morita et al., 2011; Becattini et al., 2015; Ma et al., 
2015; Okada et al., 2015). Human Th1, Th17, and Th1/17 
cells have important roles in host protection against different 
classes of pathogens. Indeed, patients with inborn errors of 
IFN‑γ immunity are susceptible to infection with mycobac‑
teria (Boisson‑Dupuis et al., 2015; Kreins et al., 2015; Okada 
et al., 2015), whereas those with inborn errors of IL‑17–me‑
diated immunity develop chronic mucocutaneous candidiasis 
(CMC; de Beaucoudrey et al., 2008; Ma et al., 2008; Milner et 
al., 2008; Liu et al., 2011; Puel et al., 2012; Okada et al., 2015).
Another subset of effector CD4+ T cells, T follicular 
helper (Tfh) cells, mediates the differentiation of B cells into 
memory cells and plasma cells in response to T cell–depen‑
dent antigens (Crotty, 2011; Tangye et al., 2013). Tfh cells 
express CXCR5, the transcription factor Bcl‑6, which is es‑
sential for Tfh generation, and a host of molecules involved 
in T cell–B cell interactions, including CD40L, inducible co‑
stimulator (ICOS), PD‑1, SAP, and IL‑21 (Crotty, 2011; Liu 
et al., 2013; Tangye et al., 2013). Many studies have addressed 
the requirements for Tfh formation. IL‑6, IL‑12, IL‑21, and 
IL‑27 can induce features of Tfh cells in human and murine 
naive CD4+ T cells in vitro (Crotty, 2011; Tangye et al., 2013). 
These findings were extended by demonstrating reduced mu‑
rine Tfh cells in vivo in the absence of one or more of these 
cytokines (Crotty, 2011; Tangye et al., 2013). Studies in mice 
also identified receptor/ligand pairs (CD40/CD40L, ICOS/
ICOS‑L, SLAM family members, and CD28/B7), specific 
signaling pathways (SAP, PI3 kinase, STAT1, and STAT3), and 
transcription factors in addition to Bcl‑6 (cMAF, IRF4, BATF, 
and Ascl2) that are involved in Tfh formation (Crotty, 2011; 
Tangye et al., 2013). More recently, an additional level of 
complexity has been added to Tfh biology, with several stud‑
ies implicating roles for TGFβ and/or IL‑23 in their forma‑
tion in humans and mice (Schmitt et al., 2014; Marshall et al., 
2015). However, TGFβ also represses murine Tfh formation 
in vivo and in vitro (Suto et al., 2008; McCarron and Marie, 
2014; Schmitt et al., 2014), indicating that the precise require‑
ments for Tfh cell development remains to be established. De‑
spite this, the importance of Tfh cells in humoral immunity is 
apparent from their dysregulated production and function in 
numerous human immunopathologies, such as autoimmunity 
and primary immunodeficiencies (PIDs; Tangye et al., 2013). 
Furthermore, frequencies of circulating Tfh (cTfh) cells cor‑
relates with the efficacy of humoral immune responses elic‑
ited after natural infection and vaccination (Pallikkuth et al., 
2012; He et al., 2013; Locci et al., 2013; Herati et al., 2014).
We and others have previously quantified CD4+ T cell 
subsets in individuals with monogenic PIDs. Biallelic muta‑
tions in IL12B1, IL12RB1, and ISG15 impaired the develop‑
ment of Th1 cells (de Beaucoudrey et al., 2010; Prando et al., 
2013; Boisson‑Dupuis et al., 2015; Ma et al., 2015), whereas 
heterozygous dominant‑negative (DN) mutations in STAT3 
or gain‑of‑function (GOF) mutations in STAT1 impaired 
development of Th17 cells (de Beaucoudrey et al., 2008; Ma 
et al., 2008, 2015; Milner et al., 2008; Liu et al., 2011). No‑
tably, loss‑of‑function (LOF) mutations in RORC impaired 
both Th17 and Th1/17 cells (Okada et al., 2015). There was 
also a paucity of cTfh cells in patients with IL10R, IL21R, 
IL12RB1, CD40LG, ICOS, NEMO, or BTK LOF mutations, 
STAT3 DN mutations, or STAT1 GOF mutations (Bossaller 
et al., 2006; Martini et al., 2011; Ma et al., 2012, 2015; Schmitt 
et al., 2013). Although these findings shed light on the re‑
quirements for generating or maintaining CD4+ T cell subsets 
in vivo, they do not necessarily discriminate between intrinsic 
and extrinsic effects of the disease‑causing mutations on these 
processes. We therefore set out to analyze the ability of naive 
CD4+ T cells from individuals with distinct disease‑causing 
mutations to differentiate into effector populations in vitro. 
Specifically, this included individuals with heterozygous LOF 
or DN mutations in STAT1, STAT3 or IFN GR1, X‑linked 
hemizygous LOF mutations in CD40LG, NEMO, or BTK; 
bi‑allelic recessive LOF mutations in IL21, IL21R, IL10R, 
ICOS, IL12RB1, IFN GR1, or TYK2; or heterozygous 
dominant GOF mutations in STAT1 (Table S1; 88 patients 
total). In doing so, we have now determined the cell intrinsic 
requirements and signaling pathways necessary to generate 
human Th1, Th17, Tfh‑type, and IL‑10–producing effector 
cells. These findings provide insight into the pathophysiology 
of diseases characterized by impaired cell‑mediated and hu‑
moral immunity and infectious susceptibility in the setting of 
human primary immune deficient states.
RES ULTS
Although IL‑12 is the key inducer of Th1 cells (O’Shea and 
Paul, 2010; Zhu and Paul, 2010; Deenick et al., 2011; Ziel‑
inski et al., 2011; Vahedi et al., 2013), it also induces IL‑21, a 
feature of Tfh cells, in human activated naive CD4+ T cells, 
and endows these cells with the capacity to induce B cell 
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differentiation in vitro (Ma et al., 2009, 2012; Schmitt et al., 
2009). It was recently observed that both Bcl‑6 and IL‑21 were 
strongly induced in human naive CD4+ T cells after culture 
with IL‑23 and/or TGF‑β (Schmitt et al., 2014). Furthermore, 
human naive CD4+ T cells cultured with TGF‑β and IL‑23 or 
under Th17 conditions (i.e., TGF‑β/IL‑1β/IL‑6/IL‑23) were 
more efficient than IL‑12–primed T cells at inducing B cell 
differentiation in vitro, implicating TGFβ as a key driver of Tfh 
development and function in humans (Schmitt et al., 2014). 
This is consistent with findings demonstrating that human and 
murine Th17 cells can promote B cell differentiation (Annun‑
ziato et al., 2007; Mitsdoerffer et al., 2010). To extend these 
findings, we systemically compared different in vitro culture 
conditions for their ability to induce key features of human 
Th1, Th17, and Tfh cells. This would then facilitate elucidation 
of the molecular requirements for generating these effector 
cells from naive CD4+ T cells with defined mutations in spe‑
cific signaling pathways.
IL-12 potently and selectively induces IL-21 expression in 
human naive CD4+ T cells
Naive CD4+ T cells from healthy donors were cultured under 
Th0‑, Th1‑, Th2‑, or Th17‑polarizing conditions for 5 d and 
then assessed for production and expression of cytokines and 
transcription factors associated with these effector fates. As 
expected, IL‑12 in the Th1 culture induced the greatest pro‑
portion of cells expressing IFN‑γ (Fig. 1 A) and highest levels 
of TBX21/T‑bet, as determined both by qPCR (Fig. 1 B) and 
intracellular staining (Fig. 1 C and Table 1). Similarly, secretion 
of IL‑5 and IL‑13, and expression of GATA3 mRNA and 
protein, by naive CD4+ T cells were greatly increased by Th2 
culture conditions, whereas this culture significantly reduced 
basal levels of T‑bet observed in Th0 condition (Fig. 1, B and 
C; and Table 1). The Th17 culture induced significantly higher 
levels of IL‑17A, IL‑17F (Fig. 1 A), and RORC (Fig. 1 B) 
than the other cultures, and actively repressed Th2 cytokines 
and GATA3 (Fig. 1, A–C; and Table 1). RORγt protein was 
also detectable in a small but significant population of naive 
CD4+ T cells cultured under Th17, but not Th0, Th1, or Th2, 
conditions (Fig. 1 C and Table 1). Consistent with previous 
findings (Ma et al., 2009, 2012; Schmitt et al., 2009), IL‑21 
was most strongly induced by IL‑12/Th1 culture, whereas the 
effect of Th2 and Th17 cultures on IL‑21 expression did not 
exceed that of the Th0 culture (Fig. 1 A). However, induction 
of the signature Tfh cytokine IL‑21 did not correlate with 
expression of Bcl6 (Fig. 1, B and C). Rather, Bcl6 was only 
induced in the Th17 culture (Fig. 1, B and C; and Table 1). 
The nature of IL‑21–expressing cells in the Th1 culture was 
further explored by determining coexpression of IFN‑γ. IL‑12 
induced approximately equal proportions of naive CD4+ T 
cells that were IFN‑γ+, IL‑21+, or IL‑21+IFN‑γ+ (Fig. 1 D). 
This demonstrates that IL‑12 can induce IFN‑γ+ Th1 cells, 
IL21+ Tfh‑type cells, and Th1/Tfh transitional type cells ex‑
pressing both cytokines.
IL-12 induces key phenotypic and functional features of Tfh 
cells in human naive CD4+ T cells
To extend these studies, we assessed in vitro cultures of naive 
CD4+ T cells for additional features of Tfh cells. After 3 d 
of in vitro culture, expression of CXCR5 (Fig. 2 A), ICOS 
(Fig. 2 B), CD40L (Fig. 2 C), and PD‑1 (not depicted) was 
significantly greater on naive CD4+ T cells cultured under 
Th1 conditions compared with those subjected to Th0 or 
Th2 cultures. Interestingly, although Th17 conditions had the 
greatest effect on CXCR5, they had no effect on ICOS and 
actually down‑regulated CD40L (Fig. 2, A–C), which is in‑
consistent with a Tfh fate despite high expression of Bcl6. In 
terms of B cell differentiation, naive CD4+ T cells cultured 
under Th1 conditions induced abundant amounts of Ig secre‑
tion by co‑cultured B cells, whereas CD4+ T cells subjected 
to Th2‑ and Th17‑polarizing conditions exhibited minimal, 
if any, ability to induce B cell differentiation (Fig. 2 D). This 
is consistent with selective high level IL‑21 expression by 
IL‑12–primed cells. Similarly, the lack of B cell help provided 
by Th17‑induced CD4+ T cells mirrored not only their poor 
expression of IL‑21 (Fig. 1 A), but also reduced expression 
of CD40L by these cells (Fig.  2 C). The unique ability of 
Th1‑cultured naive CD4+ T cells to promote Ig secretion by 
co‑cultured B cells was further demonstrated by the exclusive 
induction of PRDM1 (encoding Blimp‑1), a master regula‑
tor of plasma cell formation (Nutt et al., 2011), in cultures 
of B cells and IL‑12–treated CD4+ T cells, but not when B 
cells were cultured with Th0, Th2, or Th17 cells (Fig. 2 E). 
Collectively, these data establish that IL‑12 strongly induces 
phenotypic and functional attributes of Tfh cells in human 
naive CD4+ T cells in vitro. One exception is Bcl‑6, which is 
not required for these initial events in human Tfh differenti‑
ation. These findings parallel observations that murine CD4+ 
T cells express CXCR5 and IL‑21 before expressing Bcl‑6 
(Liu et al., 2012, 2013). Thus, the in vitro culture we employed 
corresponds to early events in differentiation of human naive 
CD4+ T cells to a Tfh fate.
Differential induction of phosphorylation of STATs by  
in vitro–polarizing cultures
The focus of this study is to determine molecular require‑
ments for human CD4+ T cell differentiation. To do this, we 
used CD4+ T cells from individuals with mutations in vari‑
ous signaling pathways, including cytokine receptors (IL10R, 
IL12RB1, IL21R, and IFN GR1) and downstream compo‑
nents (TYK2, STAT1, and STAT3; Table S1). Thus, it was 
necessary to establish which STAT molecules are activated in 
normal naive CD4+ T cells in response to the different stim‑
ulatory conditions used in our in vitro cultures. The rationale 
of this is to determine, first, direct effects of the polarizing 
conditions on STAT activation and, second, possible indi‑
rect effects after induction of cytokines that may act auton‑
omously to activate specific STATs. Th1/IL‑12 or Th2/IL‑4 
stimuli induced strong phosphorylation of STAT4 or STAT6, 
respectively (Fig. 3). STAT1 was also weakly phosphorylated 
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in response to Th2 polarizing conditions, while in Th17 con‑
ditions, IL‑10 or IL‑21 activated STAT1 and STAT3, but had 
little effect on STAT4 or STAT6 (Fig. 3). IFN‑γ only acti‑
vated STAT1 (Fig. 3). Thus, consistent with previous studies 
(Leonard, 2001), different stimuli induced distinct but over‑
lapping patterns of activation of STAT molecules.
Monogenic mutations impact the in vitro differentiation of 
naive CD4+ T cells into IL-21–expressing Tfh-type cells
We recently examined >110 individuals with defined mono‑
genic mutations that underlie distinct PID states to identify 
key molecular regulators of human CD4+ T cell differentia‑
tion in vivo. This revealed that the generation and/or func‑
tion of cTfh cells was compromised by STAT3 DN, IL21, 
IL21R, IL10R, CD40LG, NEMO, ICOS, or BTK LOF, or 
STAT1 GOF mutations (Ma et al., 2015). As expression of 
most of these genes is not restricted to CD4+ T cells, iden‑
tifying perturbations in cTfh cells does not indicate whether 
this is T cell intrinsic or extrinsic. To gain further insight into 
the molecular requirements for generating human Tfh cells, 
we examined the ability of naive CD4+ T cells isolated from 
patients with mutations in key signaling pathways (Table 
S1) to differentiate into Tfh‑type cells in vitro under appro‑
priate culture conditions.
Figure 1. In vitro induction of features of Tfh cells in human naive CD4+ T cells. Naive CD4+ T cells were isolated from peripheral blood of healthy 
donors, and then cultured with T cell activation and expansion (TAE) beads alone (Th0) or under Th1 (+IL-12), Th2 (+IL-4), or Th17 (+TGF-β, IL-1β, IL-6, IL-21, 
IL-23, and PGE2) conditions for 5 d. After this time, the cells were harvested and analyzed for (A) production of IFN-γ, IL-5/IL-13, IL-17A/IL-17F, and IL-21 
by intracellular staining or cytometric bead array (CBA; mean ± SEM; n = 8–17); and (B and C) expression of TBX21/Tbet, GATA3, RORC/Rorγt, or BCL6 by 
qPCR (B) or flow cytometry (C). The graphs in B correspond to the fold change (mean ± SEM; n = 10–17) in expression of the indicated transcription factor 
relative to Th0 culture. Histograms depicted in C are representative of three to five independent experiments. (D) Coexpression of IL-21 and IFN-γ by Th0- or 
Th1-stimulated human naive CD4+ T cells was determined by intracellular staining and flow cytometry. The graphs depicts the mean ± SEM of cytokine-ex-
pressing cells derived from nine different experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, compared with Th0 (ANO VA).
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When naive CD4+ T cells from PID patients were ex‑
amined in vitro, STAT3 DN, IL21R, CD40LG, or IFN GR1 
LOF, or STAT1 GOF, mutations significantly impaired their 
ability to become IL‑21+ cells in response to IL‑12 in vitro 
(Fig. 4 A). The specificity of this response was established 
by demonstrating that IL12RB1 LOF mutations abolished 
IL‑21 induction, whereas naive CD4+ T cells from the 
single IL21‑deficient patient thus far reported (Salzer et 
al., 2014) failed to express detectable amounts of IL‑21 
(Fig. 4 A). Importantly, hematopoietic stem cell transplant 
of a CD40LG‑deficient patient improved the ability of 
his naive CD4+ T cells to express IL‑21 in response to 
IL‑12 (i.e., pretransplant: 1.0% IL‑21+ cells; after trans‑
plant: 21.0% IL‑21+ cells). Mutations in IL10R, TYK2, or 
NEMO also reduced IL‑21 expression by IL‑12–stimulated 
naive cells (Fig. 4 A); however, these differences did not 
reach statistical significance due to the small sample size 
(IL10R and TYK2) or the variability of NEMO muta‑
tions on lymphocyte function. For instance, responses of 
three NEMO‑deficient patients were intact, whereas re‑
Table 1. Induction of transcriptional regulators of CD4+ T cell differentiation in vitro
Transcription factor In vitro polarizing conditions
Th0 Th1 Th2 Th17
Tbet (ΔMFI) 1.0 1.4 ± 0.07a 0.8 ± 0.09 0.65 ± 0.1a
GATA3 (ΔMFI) 1.0 0.75 ± 0.05 3.1 ± 0.16 § 0.4 ± 0.02b
RORγt (ΔMFI) 1.0 1.25 ± 0.13 1.2 ± 0.03 1.5 ± 0.08a
RORγt (%) 0.5 ± 0.2% 0.66 ± 0.1% 0.66 ± 0.15% 6.3 ± 0.7%c
Bcl-6 (ΔMFI) 1.0 1.41 ± 0.08a 1.3 ± 0.1 2.4 ± 0.08c
Naive CD4+ T cells were isolated from peripheral blood of healthy donors, and then cultured with TAE beads alone (Th0) or under Th1, Th2, or Th17 conditions for 5 d. After this time, the 
cells were harvested and expression of Tbet, GATA3, RORγt, or Bcl-6 was determined by intracellular staining and flow cytometry. The values represent either the fold change (ΔMFI, mean 
± SEM; n = 3–5) in expression of the indicated transcription factor relative to Th0 culture, or the % of cells expressing RORγt (n = 3). 
aP < 0.05.
bP < 0.01.
cP < 0.0001 (ANO VA).
Figure 2. IL-12 selectively induces Tfh phenotype and function in human naive CD4+ T cells. Peripheral blood naive CD4+ T cells were cultured in 
media only (Nil) or with TAE beads alone (Th0) or under Th1, Th2, or Th17 conditions. (A–C) After 3 d, the cells were harvested and expression of (A) CXCR5, 
(B) ICOS, and (C) CD40L were determined by flow cytometry. The histogram plots (top) depict expression of the indicated surface receptor by cells cultured 
in media (solid gray) or under Th0 (blue), Th1 (green), Th2 (orange), or Th17 (red) conditions. The graphs (bottom) represent fold change in expression of the 
indicated cell surface marker relative to the Th0 culture (mean ± SEM; n = 4). *, P < 0.05; **, P < 0.01; ****, P < 0.0001 compared with Th0 (ANO VA). (D and 
E) After 5 d, activated CD4+ T cells were treated with mitomycin C and co-cultured with sort-purified allogeneic naive B cells in the presence of TAE beads 
for 7 d. (D) Secretion of IgM, IgG, and IgA (n = 3) and (E) expression of PRDM1 (Blimp1; n = 2) relative to the Th0 cultures were determined by ELI SA and 
qPCR, respectively. Values represent mean ± SEM. **, P < 0.01.
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sponses of four other patients were greatly reduced (<25% 
of controls). This is consistent with extreme variability in 
the cellular phenotypes and clinical presentation of NE‑
MO‑mutated individuals (Orange et al., 2004; Hanson et 
al., 2008; Boisson‑Dupuis et al., 2015). In contrast, STAT1, 
BTK, or ICOS LOF mutations had no significant effect on 
IL‑12–induced IL‑21 expression. In our cohort of patients 
with LOF CD40LG mutations, there were three individuals 
with hypomorphic mutations and milder disease. Inter‑
estingly, naive CD4+ T cells from these patients exhib‑
ited a normal capacity to differentiate into IL‑21+ cells 
in response to IL‑12 (CD40L*; Fig. 4 A), consistent with 
normal frequencies of cTfh cells in these individuals (Ma 
et al., 2015). Thus, pathways involving IL12RB1, STAT3, 
STAT1, IL21R, CD40LG, and possibly NEMO, IL10R, 
and TYK2, are key for inducing IL‑21 expression in human 
naive CD4+ T cells under Tfh‑inducing conditions in vitro.
Effects of monogenic mutations on the in vitro generation 
of Th1, Th2, and Th17 cells
To establish whether the inability of naive CD4+ T cells from 
some PID patients to yield IL‑21+ Tfh‑type cells resulted 
from a global impairment in activation, we assessed these cells 
for IL‑2 expression, as well as their ability to differentiate to 
other effector lineages in vitro. Comparable proportions of 
naive CD4+ T cells expressed IL‑2, irrespective of genotype, 
in response to Th0 stimulation (Fig. 4 B). Similarly, although 
STAT3 DN, IL21R, CD40LG LOF, and STAT1 GOF mu‑
tations compromised the ability of naive CD4+ T cells to ac‑
quire IL‑21 in response to IL‑12 (Fig. 4 A), these same cells 
up‑regulated TBX21 and produced IFN‑γ comparably to 
normal naive CD4+ T cells under Th1/Tfh conditions (Fig. 4, 
C and D; Fig. S1 A). There was actually a significant increase 
in IFN‑γ production by STAT3 mutant naive CD4+ T cells 
in response to IL‑12 stimulation, indicating STAT3 signaling 
Figure 3. Differential induction of STAT activation by in vitro–polarizing conditions. Naive CD4+ T cells were cultured with TAE beads for 4 d. After 
this time, the cells were harvested, and then cultured in media alone (blue histogram) or under Th1 (+IL-12), Th2 (+IL-4), or Th17 (+TGF-β, IL-1β, IL-6, IL-21, 
IL-23, and PGE2) conditions, or with IL-10, IL-21, or IFN-γ (red histograms) for 30 min. Phosphorylation of STAT1, STAT3, STAT4, and STAT6 was determined 
by intracellular staining and flow cytometry. The data are representative of experiments performed on cells from two to three different donors.
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restrains Th1 differentiation (Fig. 4 D and Fig. S1 A). This in‑
dicates a selective impairment in differentiating into Tfh‑type, 
but not Th1‑type, cells in response to IL‑12. IL‑12–mediated 
IFN‑γ induction was strongly reduced by LOF STAT1, IFN 
GR1, and TYK2 mutations, and abolished by IL12RB1 mu‑
tations (Fig. 4 D and Fig. S1 A). Induction of GATA3 was 
also intact in most populations of naive CD4+ T cells when 
subjected to Th2‑polarizing conditions (Fig. 4 E).
Consistent with previous studies (de Beaucoudrey et 
al., 2008; Ma et al., 2008; Milner et al., 2008), STAT3 DN 
mutations abolished induction of IL‑17A, IL‑17F (Fig. 4 F), 
and RORC (Fig. S1 B) in naive CD4+ T cells cultured under 
Th17‑polarizing conditions. We have now found that, in ad‑
dition to compromising IL‑12–mediated IL‑21 induction in 
naive CD4+ T cells, LOF mutations in IL12RB1 and TYK2 
abolished, whereas STAT1 GOF and IL21R, CD40LG, 
NEMO, and IFN GR1 LOF mutations impaired, Th17 gen‑
eration from naive precursors (Fig. 4 F). In contrast, STAT1 
LOF mutations had no effect, whereas IL‑10R deficiency in‑
creased production of IL‑17F (Fig. 4 F). Thus, signaling path‑
ways involving IL‑23/IL‑12Rβ1/TYK2/STAT3, IL‑21R/
STAT3, and NEMO downstream of IL‑1β or TCR (Hanson 
et al., 2008) are required to induce human Th17 cells, a pro‑
cess also compromised by STAT1 GOF mutations. To extend 
these findings, we assessed the effects of Th17‑polarizing cul‑
ture conditions on expression of IL‑17A and IL‑17F by mem‑
ory CD4+ T cells. Consistent with our previous findings (Ma 
et al., 2015), the proportions of IL‑17A/F+ memory CD4+ T 
cells detected under Th0 and Th17 culture conditions was re‑
duced by STAT3 DN, STAT1 GOF, and IL21R, NEMO, and 
IL12RB1 LOF mutations (Fig. S1 C). In contrast LOF mu‑
tations in STAT1, CD40LG, BTK, ICOS, or IFN GR1 had 
no effect on amplifying Th17 responses of memory cells, yet 
lack of IL‑10R resulted in an exaggerated response (Fig. S1 
C). Thus, the consequences of pathogenic mutations on the 
ability of naive CD4+ T cells to differentiate into Th17 cells in 
vitro are shared by in vivo–generated memory CD4+ T cells.
IL-21R/STAT3 signaling is required for IL-10 production by 
naive CD4+ T cells in vitro
IL‑10 is a pleiotropic cytokine produced by numerous CD4+ 
T cell subsets and is involved in suppressing immune responses 
Figure 4. Impact of disease-causing mu-
tations on differentiation of naive CD4+ T 
cells to Th1, Th2, Th17, and Tfh fates in 
vitro. Naive CD4+ T cells were isolated from 
peripheral blood of healthy donors or patients 
with mutations in STAT3, STAT1, IL21/R, IL10R, 
CD40LG, NEMO, BTK, ICOS, IL12RB1, IFN GR1, or 
TYK2, and then cultured with TAE beads alone 
(Th0) or under Th1/Tfh (+IL-12), Th2 (+IL-4), 
or Th17 (+TGF-β, IL-1β, IL-6, IL-21, and IL-23) 
conditions for 5 d. Cells were then harvested 
and analyzed for expression of cytokines and 
transcription factors. (A) Percentage of cells 
expressing IL-21 in response to Tfh/IL-12 stim-
ulation. (B) Percentage of cells expressing IL-2 
in Th0 culture. (C and D) Induction of TBX21 
(C) and IFN-γ (D) expression after Th1/IL-12–
polarizing culture. (E) Induction of GATA3 in 
response to Th2/IL-4 stimulation. (F) Induction 
of IL-17A and IL-17F secretion after Th17-po-
larizing culture. Controls, n = 17–48; STAT3DN, 
n = 2–10; STAT1GOF, n = 5–14; STAT1LOF, n = 
3–8; IL21R, n = 3–5 experiments; IL21 n = 1; 
IL10R, n = 1–2; CD40LG, n = 3–9 (CD40LG* 
(MILD), n = 3); NEMO, n = 2–7; BTK, n = 5–8; 
ICOS, n = 2–7; IL12RB1, n = 3–8; IFN GR1, n = 
2–6; TYK2, n = 2–3. *, P < 0.05; **, P < 0.01; 
***, P < 0.001; ****, P < 0.0001, compared with 
Th0 (ANO VA; Student’s t test). The dashed 
lines indicate the mean percentage of IL-21+ 
(A) or IFN-γ+ (D) cells, or secretion of IL-17A/F 
(F), detected under Th0 conditions. Note that 
data for IL-17A/F production by TYK2-deficient 
naive CD4+ T cells was presented in Kreins et 
al. (2015), but is shown here for comparison.
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and promoting human B cell differentiation (Hirahara et al., 
2013; Moens and Tangye, 2014). Thus, we investigated which 
conditions most efficiently induce IL‑10 production in vitro. 
Th2 polarization induced a significantly increased proportion 
of IL‑10+ cells compared with the other conditions (Fig. 5 A). 
This was also observed for IL‑10 secretion (Fig. 5 B). Th17 
conditions induced greater levels of IL‑10 compared with the 
Th0 culture; however, the absolute levels were less than those 
induced by the Th2 culture (Fig.  5  B). Thus, naive CD4+ 
T cells produced substantial amounts of IL‑10 after stimu‑
lation with Th2‑ or Th17‑polarizing conditions, consistent 
with studies showing IL‑10 production by human Th2 and 
Th17 cells (Sornasse et al., 1996; Boniface et al., 2009; Sara‑
iva and O’Garra, 2010). When naive CD4+ T cells from PID 
patients were investigated, STAT3 DN or IL21R LOF muta‑
tions significantly impaired Th2 induction of IL‑10, whereas 
none of the other mutations had any effect (Fig. 5 C). These 
same mutations abolished IL‑10 secretion induced under 
Th17 conditions (Fig. 5 D). Thus, signaling through IL‑21R/
STAT3 represents the major pathway required for inducing 
IL‑10 production by human CD4+ T cells.
Transcriptional analysis reveals similar differentiation states 
between normal and PID naive CD4+ T cells
Although our in vitro functional studies revealed marked 
defects in the differentiation capacity of naive CD4+ T cells 
from PID patients with distinct disease‑causing mutations, 
the finding that these same naive CD4+ T cells could be in‑
duced to express comparable levels of IL‑2 as naive CD4+ T 
cells from healthy controls, or could differentiate normally 
under some polarizing conditions (Figs. 4 and 5), suggested 
that the differentiation defects did not result from global de‑
fects in lymphocyte activation. However, it remained possible 
that such mutations compromised the in vivo development 
of CD4+ T cells such that cells isolated from PID patients 
according to a naive surface phenotype were different to 
phenotypically matched cells from healthy donors. Thus, it 
was necessary to provide further evidence that naive CD4+ T 
cells from PID patients were of a comparable differentiation 
state as those from healthy controls. To formally investigate 
this, we performed microarray analysis on naive CD4+ T cells 
(CD4+CD45RA+CCR7+CD127hiCD25lo) from healthy do‑
nors (n = 7) and 19 PID patients corresponding to 11 differ‑
ent gene mutations (STAT3DN, STAT1GOF, STAT1LOF, IL21R, 
IL10R, CD40LG, NEMO, BTK, ICOS, IL12RB1, and IFN 
GR1). We also compared these to memory CD4+ T cells from 
three healthy donors. Gene expression profiles were subjected 
to unsupervised clustering analysis by nonnegative matrix 
factorization (NMF; Brunet et al., 2004; Suan et al., 2015). 
NMF identified two molecularly distinct populations in this 
dataset (k = 2; cophenetic coefficient = 0.9999). One con‑
sisted entirely of memory CD4+ T cells, characterized by high 
expression of a memory metagene or gene signature that in‑
cluded known memory CD4+ T cell markers such as CD58, 
CCR4, CCR6, CXCR3, and GZMK (Fig. 6 A; Weng et al., 
2012). The second population comprised naive CD4+ T cells 
from both healthy controls and the different PID patients, 
marked by expression of a naive metagene that included mi‑
croRNAs and small nucleolar RNAs (Fig. 6 A). Importantly, 
visualization of naive and memory metagene expression re‑
Figure 5. Induction of IL-10 by Th2- and Th17-po-
larizing cultures is compromised by mutations in 
IL21R and STAT3. (A and B) Naive CD4+ T cells from 
healthy donors were cultured with TAE beads alone (Th0) 
or under Th1, Th2, or Th17 conditions for 5 d. After this 
time, the cells were harvested and analyzed for IL-10 pro-
duction by intracellular staining and flow cytometry (A; n = 
15) or CBA (n = 24). Values represent mean ± SEM. ****, 
P < 0.0001 compared with Th0 (ANO VA). (C and D) Naive 
CD4+ T cells from healthy donors or patients were cul-
tured with TAE beads alone (Th0) or under Th2 (C) or Th17 
(D) conditions for 5 d. IL-10 secretion was determined by 
CBA. Values represent mean ± SEM; dashed line indicates 
the mean level of IL-10 secretion under Th0 conditions. 
Controls, n = 31–35; STAT3DN, n = 6–8; STAT1GOF, n = 8; 
STAT1LOF, n = 4–5; IL21R, n = 4–5; IL10R, n = 1–2; CD40LG, 
n = 5; NEMO, n = 2–3; BTK, n = 7; ICOS, n = 3; IL12RB1, n = 
5–6; IFN GR1, n = 2–5; TYK2, n = 2–3. **, P < 0.01; ***, P < 
0.001, compared with controls (ANO VA; Student’s t test).
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vealed that naive CD4+ T cells from healthy donors and PID 
patients clustered tightly together and were indistinguishable 
(Fig. 6 B). Taken together, these data show that naive CD4+ T 
cells from PID patients were not programmed differently to 
those from normal controls and could be justifiably used to 
interrogate the function of signaling pathways.
Impaired differentiation of mutant naive CD4+ T cells is not 
a result of compromised proliferation
Many aspects of lymphocyte differentiation, such as class 
switching by naive B cells and acquisition of cytokine ex‑
pression by naive CD4+ T cells, require cell division (Tangye 
and Hodgkin, 2004; Ma et al., 2005). Thus, as several of the 
gene mutations examined could potentially influence T cell 
proliferation, another explanation for the poor differenti‑
ation of naive CD4+ T cells from PID patients into cyto‑
kine‑producing could be impaired cell division in vitro. To 
test this, naive CD4+ T cells sorted from the peripheral blood 
of healthy controls and PID patients were labeled with the di‑
vision tracking dye CFSE, and then cultured under Th0, Th1, 
Th2, or Th17 conditions. When stimulated under Th0 condi‑
tions, ∼70–90% of naive CD4+ T cells from healthy controls 
had undergone >1 division after 5 d of in vitro culture, with 
the majority of proliferating cells being in divisions four to 
seven (Fig. 7, gray filled histograms). Th1 or Th2 polarizing 
conditions slightly increased the proportions of divided cells 
(Fig. S2). Although Th17‑polarizing conditions modestly re‑
duced proliferation of naive CD4+ T cells, most likely due to 
TGFβ, the cells continued to undergo extensive rounds of 
division (Fig. S2). Importantly, naive CD4+ T cells from all 
patient groups tested—irrespective of genotype—exhibited 
proliferation (CFSE) profiles that largely overlapped those of 
normal controls (Fig. 7 and Fig. S2, black outline histograms). 
Thus, defective proliferation of naive CD4+ T cells harboring 
disease‑causing mutations does not underlie impaired differ‑
entiation of these cells into distinct effector fates, as defined 
by cytokine expression. Rather, the mutations specifically im‑
pede the cytokine‑driven differentiation process.
Functional defects in in vitro–induced Tfh-type cells due to 
specific gene mutations
Although Tfh cells are typically defined by a canonical phe‑
notype, the fundamental readout of Tfh biology is their ability 
to mediate differentiation of B cells into antibody‑secreting 
cells (Crotty, 2011; Tangye et al., 2013). Thus, we next tested 
the capacity of IL‑12–stimulated naive CD4+ T cells from 
PID patients to induce IgM secretion from co‑cultured naive 
B cells isolated from allogeneic normal donors. When naive 
CD4+ T cells from normal donor are first cultured under Th0 
conditions for 5 d, and then co‑cultured with naive B cells, 
the levels of IgM secreted are very low (i.e., 39 ± 6.5 ng/ml; 
n = 30). However, these levels were significantly increased if 
the CD4+ T cells were first cultured under Th1 conditions 
that induced a Tfh phenotype (IgM, 590 ± 100 ng/ml; P < 
0.0001). When naive CD4+ T cells from patients with STAT3 
DN, IL21R, IL10R, CD40LG, NEMO, BTK, or TYK2 LOF, 
or GOF STAT1 GOF mutations were tested in these co‑cul‑
tures, their ability to mediate B cell differentiation was greatly 
reduced (<25% of normal naive CD4+ T cells; Fig. 8 A). Con‑
sistent with the inability of IL12RB1 and IL21 mutant CD4+ 
T cells to produce IL‑21 in response to IL‑12 (Fig. 4 A), these 
cells failed to promote differentiation of co‑cultured B cells 
(Fig. 8 A). In contrast, STAT1 or ICOS LOF mutations, or 
hypomorphic CD40LG mutations in individuals whose naive 
CD4+ T cells produced normal levels of IL‑21 in vitro, did 
not impede B cell helper function of IL‑12–primed naive 
CD4+ T cells (Fig. 8 A).
Exogenous IL-21 rescues the functional Tfh 
defect in STAT1GOF mutant and IL21R- and IL10R-
deficient naive CD4+ T cells
Given the extremely strong correlation between the inability 
of IL‑12–primed mutant naive CD4+ T cells to acquire ex‑
pression of IL‑21 (Fig. 4 A) and of these cells to induce B cell 
differentiation (Fig. 8 A), we tested the hypothesis that im‑
paired B cell help was a direct result of a lack of IL‑21 produc‑
tion. For these experiments, we attempted to restore impaired 
B cell help of CD4+ T cells with STAT3 DN, IL21R, IL10R, 
or BTK LOF or STAT1 GOF mutations by supplementing 
the co‑cultures with exogenous IL‑21. Exogenous IL‑21 
greatly improved Ig secretion by IL‑12–primed naive CD4+ 
T cells with STAT1 GOF or IL21R, IL10R LOF (Fig. 8 B), 
or STAT3 DN (not depicted; Ma et al., 2012) mutations. Re‑
markably, the level of B cell help was restored to that of nor‑
mal in vitro–derived Tfh‑type cells (Fig. 8 B), confirming that 
poor IL‑21 production by these cells was responsible for in‑
effective B cell differentiation. The fact that exogenous IL‑21 
corrected defective B cell help by IL‑21R–deficient CD4+ 
T cells (Fig. 8 B) demonstrated that it exerted this effect by 
directly stimulating the B cells and not co‑cultured CD4+ 
T cells. IL‑21 did not improve B cell help of naive CD4+ T 
cells from BTK‑deficient patients (Fig. 8 B), consistent with 
intact production of IL‑21 by these cells under Tfh‑induc‑
ing conditions (Fig. 4 A). Similarly, exogenous CD40L failed 
to improve B cell help of IL‑12–primed CD40LG‑deficient 
naive CD4+ T cells (Fig. 8 C), consistent with poor produc‑
tion of IL‑21 by, and a lack of expression of CD40L on, these 
cells (Fig.  4  A and not depicted). Impaired B cell help by 
BTK mutant CD4+ T cells was also unaffected by addition of 
CD40L to the co‑cultures (Fig. 8 C).
To determine whether naive CD4+ T cells from PID 
patients exhibited additional defects after culture under 
Tfh‑inducing conditions, we examined expression of signa‑
ture molecules expressed by Tfh cells in vivo. The ability of 
naive CD4+ T cells to up‑regulate CXCR5, CD40L, ICOS 
(Fig. 8 D), and PD‑1 (not depicted) after culture under Tfh 
conditions compared with Th0 conditions was unaffected 
by STAT3 DN, IL21R, or BTK LOF or STAT1 GOF mu‑
tations. Thus, these mutations do not impair responsiveness 
of naive CD4+ T cells to IL‑12 with respect to modifying 
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Figure 6. Unsupervised clustering of CD4+ T cells from PID and normal healthy donors by nonnegative matrix factorization (NMF). (A) Heat map 
of log2-transformed expression data, with genes organized into naive and memory metagenes. Expression levels are indicated by the color scale, with red 
and blue respectively representing high and low relative expression. (B) Visualization of expression levels of naive and memory metagenes by memory CD4+ 
T cells and naive CD4+ T cells from normal healthy donors and PID patients. Naive CD4+ T cells clustered tightly together and could not be distinguished 
from each other irrespective of genotype.
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their phenotype, akin to their intact production of IFN‑γ. In 
contrast, STAT3 DN or IL21R LOF mutations did reduce 
Th17‑mediated up‑regulation of CXCR5 on naive CD4+ T 
cells (Fig. 8 D). However, CD40L expression by naive CD4+ 
T cells harboring these mutations continued to be repressed 
by Th17 cultures (Fig. 8 D). Thus, IL‑21R/STAT3 signaling 
makes a dominant contribution to enhancing CXCR5 ex‑
pression induced by Th17 stimuli, but this pathway does not 
regulate CD40L expression under these conditions.
B cell function in PID patients
Many of the patient groups studied here—STAT3 DN, 
CD40LG, NEMO, IL21R, ICOS LOF, and STAT1 GOF—
exhibit defects in humoral immunity (Table S1). The findings 
of altered naive CD4+ T cell differentiation for some of these 
individuals suggest the humoral immune defects are CD4+ T 
cell intrinsic. However, several of the genes investigated are 
broadly expressed in immune cells, including B cells. Thus, it 
was important to address the possibility that intrinsic B cell 
defects also contributed to poor antibody responses in some 
PIDs. Isolated naive B cells and, where possible, memory cells 
were cultured with CD40L/IL‑21, a culture that induces 
high‑rate differentiation of human B cells into antibody‑se‑
creting cells (Bryant et al., 2007; Avery et al., 2010). Consis‑
tent with our previous studies (Avery et al., 2010; Deenick et 
al., 2013), STAT3 DN and IL21R LOF mutant naive B cells 
were unresponsive to the stimulatory effects of IL‑21 (Fig. 9, 
A and B). A similar but less severe phenotype was noted for 
STAT1 GOF mutant naive B cells, with 3–10‑fold less se‑
cretion of IgM IgG and IgA (Fig. 9, A and B). Interestingly, 
although IgM production was intact for B cells with other 
disease‑causing mutations, including severe or hypomor‑
phic CD40LG mutations (Fig. 9 A), naive B cells with LOF 
NEMO mutations exhibited reduced secretion of IgG and 
IgA (Fig. 9 B), consistent with studies showing impaired class 
switching of NEMO‑deficient B cells in vitro in response to 
CD40L and IL‑2, IL‑4, and/or IL‑10 (Jain et al., 2001; Han‑
son et al., 2008). Similar results were observed for memory B 
cells from the different patient groups, with the exceptions of 
STAT3 DN, STAT1 GOF, and NEMO LOF mutant memory 
B cells, which exhibited greatly improved production of all Ig 
isotypes (Fig. 9, C and D). The ability of NEMO‑deficient 
memory B cells to secrete normal levels of Ig in vitro may 
explain the variability in serum Ig in these patients (Döffinger 
et al., 2001; Hanson et al., 2008). The normal production of 
IgM, but reduced production of IgG and IgA, by memory B 
cells from CD40LG‑ and ICOS‑deficient patients reflects the 
predominance of IgM+, and thus the lack of class switched, 
memory B cells in these individuals (Ma et al., 2015), rather 
than a B cell–intrinsic defect in class switching. Indeed, the 
finding of intact Ig secretion by CD40LG mutant B cells, irre‑
spective of the severity of the mutation, highlights the B cell–
extrinsic nature of the defect in humoral immunity in these 
individuals, consistent with the seminal work from Mayer et 
Figure 7. Disease-causing mutations do 
not compromise proliferation of naive CD4+ 
T cells. Naive CD4+ T cells from healthy donors 
(solid gray histograms) and patients (overlay 
black histograms) with the indicated gene mu-
tations were labeled with CFSE, and then cul-
tured with TAE beads (Th0) for 5 d. After this 
time, the cells were harvested and analyzed 
for proliferation by assessing CFSE dilution. 
Histograms are representative of experiments 
performed using naive CD4+ T cells from nine 
different healthy controls, two patients with 
mutations in STAT3, STAT1, CD40LG, NEMO, 
BTK, IL12RB1, or IFN GR1, or individual patients 
with mutations in IL21R, IL10R, or ICOS.
 o
n
 August 30, 2016
jem.rupress.org
D
ow
nloaded from
 
Published July 11, 2016
Regulation of human CD4+ T cell differentiation | Ma et al.1600
Figure 8. Impaired Tfh function of naive CD4+ T cells caused by mutations affecting IL-21/STAT3 signaling or cognate T–B cell interactions. 
(A) Naive CD4+ T cells from healthy controls or PID patients cultured under Th0 or Th1 conditions that induce a Tfh phenotype for 5 d were then treated 
with mitomycin C and co-cultured with sort-purified normal allogeneic naive B cells in the presence of TAE beads. Secretion of IgM was determined after 
7 d; values are expressed as IgM secretion (mean ± SEM) as a percentage of the response induced by normal naive CD4+ T cells assessed concurrently. 
Controls, n = 33; STAT3DN, n = 6; STAT1GOF, n = 8; STAT1LOF, n = 4; IL21R, n = 5; IL21, n = 1; IL10R, n = 2; CD40LG, n = 5; CD40LG*, n = 3; NEMO, n = 3; BTK, 
n = 7; ICOS, n = 4; IL12RB1, n = 4; TYK2, n = 1. (B and C) Co-cultures described in A were supplemented with exogenous IL-21 (B) or CD40L (C) on day 0; 
IgM secretion was determined after 7 d. The dotted line indicates the relative response (mean ± SEM) of control naive CD4+ T cells (normalized to 100%). 
(D) Naive CD4+ T cells from healthy controls or patients with STAT3DN, IL21R, or BTK LOF mutations or STAT1 GOF mutations were cultured under Th0, Th1/
Tfh, or Th17 conditions. After 3 d, the cells were harvested, and expression of CXCR5, CD40L, or ICOS was determined by flow cytometry. The histogram 
plots depict expression of the indicated surface receptor on cells cultured under Th0 (blue), Th1/Tfh (green), or Th17 (red) conditions. The graphs represent 
fold change (mean ± SEM) in expression of the indicated cell surface marker normalized to the Th0 culture (dashed line). Controls, n = 5; STAT3LOF, n = 3; 
STAT1GOF, n = 2; IL21R, n = 2; BTK, n = 3.
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al. (1986). Lastly, as a result of the limited numbers of avail‑
able cells, we could only perform cultures using total B cells 
from TYK2‑deficient patients (Kreins et al., 2015). Despite 
this limitation, we found comparable proportions of Ig‑se‑
creting cells (Fig. 9 E) and levels of Ig secretion (Fig. 9 F) by 
normal and TYK2‑deficient B cells in response to CD40L/
IL‑21 stimulation. However, TYK2 mutations did reduce B 
cell differentiation in response to CD40L/IL‑10 (IgM, 540 
± 230 ng/ml vs. 100 ± 10 ng/ml; IgG, 75 ± 25 ng/ml vs. 14 
± 6 ng/ml; IgA, 345 ± 75 ng/ml vs. 67 ± 36 ng/ml; n = 3). 
Thus, although intrinsic B cell defects may impact humoral 
immunity in the setting of some PIDs, the inability of naive 
CD4+ T cells to acquire functional attributes of Tfh cells will 
have a predominant influence on generating productive an‑
tibody‑mediated immune responses in many of the affected 
individuals studied here.
DIS CUS SION
Human CD4+ T cells contribute to immune‑mediated pro‑
tection against a broad array of infections. This reflects their 
dynamic ability to differentiate into distinct effector subsets 
that cooperate with other immune cells to protect the host 
against infection with specific pathogens (O’Shea and Paul, 
2010; Zhu and Paul, 2010; Zielinski et al., 2011; Vahedi et 
al., 2013; Becattini et al., 2015). The relevance of these sub‑
sets is revealed by PIDs that are characterized by an inabil‑
ity to generate a protective immune response against defined 
pathogens and the associated lack of functional CD4+ T cells. 
An example of this is an absence of Th17 cells resulting from 
STAT3 DN (de Beaucoudrey et al., 2008; Ma et al., 2008; 
Milner et al., 2008), RORC LOF (Okada et al., 2015), or 
STAT1 GOF (Liu et al., 2011; Puel et al., 2011) mutations 
and CMC in these individuals. Thus, analyzing human CD4+ 
T cell function in PIDs provides opportunities to determine 
mechanisms underlying disease pathogenesis plus the molec‑
ular requirements for lymphocyte differentiation. By using 
this approach, we have now revealed the consequences of 
mutations responsible for several PIDs on human CD4+ T 
cell differentiation, with implications for the pathophysiol‑
ogy of these conditions.
IL21R, CD40LG, or NEMO LOF and STAT1 GOF 
mutations impaired the generation of IL‑21+ Tfh‑type cells 
Figure 9. Functional in vitro responses of naive and memory B cells from immunodeficient patients. Naive (A and B) and memory (C and D) B cells 
were isolated from the peripheral blood of healthy donors or patients with mutations in STAT3, STAT1 (LOF/GOF), IL21R, IL10R, CD40LG (null and hypomor-
phic [CD40LG*]), NEMO, ICOS, IL12RB1, or IFN GR1, and then cultured with CD40L/IL-21. Secretion of IgM (A and C), IgG and IgA (B and D) was determined 
after 7 d by Ig heavy chain specific ELI SAs. Values represent mean ± SEM. Controls, n = 25; STAT3DN, n = 6; STAT1GOF, n = 9; STAT1LOF, n = 6; IL21R, n = 4; 
IL10R, n = 2; CD40LG, n = 4; NEMO, n = 5; ICOS, n = 4; IL12R, n = 5; IFN GR1, n = 6. (E and F) total B cells were isolated from healthy donors or patients with 
mutations in TYK2 (n = 3), and then cultured with CD40L alone or CD40L/IL-21. (E) The proportion of cells acquiring a plasmablast phenotype (CD38hiCD27hi) 
was determined after 5 d by flow cytometry. (F) Ig secretion was determined after 7 d.
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from naive CD4+ T cells in response to IL‑12, whereas such 
cells from BTK‑deficient patients failed to induce B cell dif‑
ferentiation despite expressing IL‑21. This substantially ex‑
tends our previous findings that STAT3 DN and IL12RB1 
LOF mutations diminish the ability of naive CD4+ T cells 
to become Tfh cells in vitro (Ma et al., 2012). These in vitro 
defects recapitulate the paucity of cTfh cells in patients with 
STAT3 DN, NEMO, BTK, IL21R, or CD40LG LOF or 
STAT1 GOF mutations (Ma et al., 2015) and correlated 
with impaired humoral immunity in these individuals. These 
findings provide novel insights into the generation of human 
Tfh cells (Fig. 10). First, the observation that IL‑12–mediated 
induction of IL‑21 in naive CD4+ T cells was comparably 
reduced by STAT3 or IL21R LOF mutations implied that 
IL‑12 directly activated STAT3 to induce a Tfh‑like fate, or 
STAT3 was required secondarily to induction of IL‑21, which 
then promoted its own expression via STAT3. As IL‑12 ac‑
tivated STAT4, but not STAT3, yet IL‑21 activated STAT3, 
the latter scenario is more likely. Thus, IL‑12 induces a low 
level of IL‑21 in a STAT4‑dependent manner, which then 
substantially up‑regulates its own production in a STAT3‑de‑
pendent manner (Fig. 10; Caprioli et al., 2008). This explains 
the reduction, but not complete abolition, of IL‑12–induced 
IL‑21 production in STAT3‑ and IL21R‑deficient CD4+ T 
cells, with the low levels of IL‑21 observed being induced by 
an IL‑12/STAT4‑dependent/STAT3‑independent pathway. 
This is supported by findings in mice, where it was found that 
IL‑12 could also induce expression of IL‑21 and additional 
features of Tfh cells in vitro, and this was reduced by ∼75% by 
Stat3 deficiency but was completely abolished by Stat4 defi‑
ciency (Nakayamada et al., 2011). These findings in the setting 
of Stat‑null murine CD4+ T cells indicate that although Stat4 
is necessary for initiating IL‑12–induced Tfh differentiation, 
it is not sufficient to achieve the maximal response; this also 
requires Stat3. Overall, these findings in mice (Nakayamada 
et al., 2011) and humans reveal that the sequential activation 
of STAT4 by IL‑12 and STAT3 by IL‑21 are required to 
induce IL‑12–mediated differentiation of naive CD4+ T cells 
to a Tfh‑fate in both species. Second, our finding that STAT3 
DN, IL21R‑deficient, or STAT1 GOF CD4+ T cells up‑reg‑
ulated CXCR5, CD40L, and ICOS normally separated the 
defect in acquiring IL‑21 by IL‑12–primed naive CD4+ T 
cells from their intact ability to exhibit phenotypic features 
of Tfh cells, with the former being IL‑21/STAT3‑dependent 
and the latter likely requiring IL‑12/STAT4. This under‑
scores the central requirement of STAT3 in regulating IL‑21 
production by Tfh cells, a prerequisite for the execution of 
their effector function. Indeed, impaired Tfh‑type function 
of IL‑12–primed STAT3 DN, IL21R LOF, or STAT1 GOF 
CD4+ T cells could be restored by exogenous IL‑21. Third, 
NEMO mutations will limit Tfh formation by impairing 
TCR responses (Hanson et al., 2008), but also extrinsically 
by compromising CD40L‑induced production of IL‑12 and 
IL‑6—inducers of human Tfh cells (Ma et al., 2009; Schmitt 
et al., 2009, 2014)—by human DCs (Döffinger et al., 2001; 
Filipe‑Santos et al., 2006; Temmerman et al., 2006). Fourth, 
CD4+ T cells require CD40/CD40L interactions to differen‑
tiate into Tfh cells in vitro. A small subset of murine T cells has 
been found to express CD40, and this facilitates T cell activa‑
tion in a CD40/CD40L‑dependent manner (Hasbold et al., 
1994; Bourgeois et al., 2002). Surprisingly, we found that ac‑
tivated human naive CD4+ T cells could be induced to tran‑
siently express low levels of CD40 in vitro (unpublished data). 
Interestingly, human CD4+ T cells can be activated by reverse 
signaling through CD40L to proliferate and secrete cytokines 
(Cayabyab et al., 1994). Thus, it is possible that CD40/CD40L 
signaling initiated by interactions between activated CD4+ T 
cells is required to generate Tfh‑like cells in vitro. This would 
explain why CD40L‑deficient human naive CD4+ T cells fail 
to produce IL‑21 in response to IL‑12, even in the absence 
of CD40‑expressing APCs.
It was recently reported that TGF‑β cooperates with 
IL‑12 or IL‑23 to induce a Tfh fate in human naive CD4+ T 
cells in vitro (Schmitt et al., 2014). Although there are some 
consistencies with our findings, i.e., co‑induction of CXCR5, 
Bcl6, and RORγt in Th17 cultures, we did not find this culture 
influenced Tfh generation in vitro. Indeed, Th17 conditions 
failed to induce IL‑21 in naive CD4+ T cells and actively re‑
pressed CD40L expression, the fundamental requirements for 
Tfh cells to mediate B cell differentiation, thereby explaining 
their inability to induce B cell differentiation in vitro. Thus, 
akin to our earlier findings (Ma et al., 2009, 2012), IL‑12 
is the single cytokine that most efficiently induces Tfh‑like 
features in human naive CD4+ T cells, when features such as 
combined expression of IL‑21, CXCR5, ICOS, PD‑1, and 
induction of B cell differentiation are used as indicators of 
Tfh function. Although IL‑12 strongly induces Tfh features in 
vitro, it is not required in vivo. This is evidenced from analysis 
of IL12B (Prando et al., 2013) or IL12RB1 mutant individ‑
uals (de Beaucoudrey et al., 2010; Schmitt et al., 2013; Ma 
et al., 2015), who have intact humoral immunity and only 
subtle reductions in cTfh cells ex vivo (Ma et al., 2012, 2015; 
Schmitt et al., 2013). Thus, inputs beyond IL‑12—IL‑6, IL‑
21, IL‑27 (Ma et al., 2009, 2012; Schmitt et al., 2009; Batten 
et al., 2010), IL‑23, and TGFβ (Schmitt et al., 2014)—com‑
pensate for impaired IL‑12R signaling in vivo. This makes 
teleological sense because safeguards are needed to ensure 
effective humoral immune responses can be induced even in 
the absence of dominant signaling pathways.
Our findings also revealed important aspects of the biol‑
ogy of Th1, Th17, and IL‑10–producing cells, and associated 
pathological conditions. STAT3 DN, IL12RB1, NEMO, and 
TYK2 LOF mutations abolished (whereas IL21R, CD40LG, 
and IFN GR1 LOF and STAT1 GOF mutations impaired) 
Th17 generation from naive CD4+ T cells. IL12RB1, TYK2, 
IL21R, and STAT3 deficiency all affect Th17 polarization 
by preventing instructive signals provided by IL‑23 or IL‑21 
in this culture, whereas NEMO mutations impair Th17 dif‑
ferentiation by affecting responses through the TCR and/
or IL‑1R (Hanson et al., 2008; Fig. 10). CD40LG mutations 
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likely compromise Th17 development by impairing CD40/
CD40L‑mediated activation of T cells in a similar manner, 
as the effect of these mutations on Tfh cells. Our findings 
of impaired Th17 differentiation by naive CD4+ T cells with 
STAT3 DN, IL21R, NEMO, IL12RB1, or TYK2 LOF or 
STAT1 GOF mutations mirrors the marked deficiency in IL‑
17A, IL‑17F, and IL‑22 production by memory CD4+ T cells 
from these individuals (Kreins et al., 2015; Ma et al., 2015). 
Poor Th17 function in vivo and in vitro caused by STAT3 
DN, IL12RB1, CD40LG, or NEMO LOF, or STAT1 GOF 
mutations is consistent with CMC/Candida/fungal infec‑
tions in some of these patients (Holland et al., 2007; Han‑
son et al., 2008; de Beaucoudrey et al., 2010; Picard et al., 
2011; Cabral‑Marques et al., 2012a,b, 2014; Puel et al., 2012; 
Lovell et al., 2016; Fig. 10). Similarly, several patients with IL‑
21R deficiency had peripheral Candida infections (Kotlarz 
et al., 2014), and mild CMC was reported in one of eight 
currently identified TYK2‑deficient patient (Minegishi et al., 
2006; Kreins et al., 2015).
IL12RB1, TYK2, IFN GR1, and STAT1 LOF muta‑
tions dramatically reduced IFN‑γ–expressing cells induced 
by Th1 culture conditions. Although this was expected for 
IL12Rβ1 and TYK2 deficiency, the fact that these other mu‑
tations caused a similar phenotype highlights the importance 
of an autocrine IFN‑γ/IFN‑γR/STAT1 feed‑forward loop 
in enhancing IFN‑γ production downstream of IFN‑γ in‑
duction by IL12R/TYK2 signaling in human CD4+ T cells 
(Fig. 10). This shared functional defect of IL12RB1‑, TYK2‑, 
IFN GR1‑, and STAT1‑deficient CD4+ T cells is consistent 
with these mutations causing Mendelian susceptibility to my‑
cobacterial disease due to impaired IFN‑γ–mediated immu‑
nity (Boisson‑Dupuis et al., 2015). In contrast, STAT3 DN 
mutations increased IFN‑γ induction, indicating STAT3 nor‑
mally restrains Th1 differentiation. Heightened IFN‑γ pro‑
duction by STAT3‑deficient naive CD4+ T cells is consistent 
with an accumulation of CXCR3+ memory T cells in these 
patients (Ma et al., 2015) and their intact immunity against 
mycobacterial infection.
IL‑10 was produced by naive CD4+ T cells after Th2 
or Th17 culture and was compromised by STAT3 DN or 
IL21R LOF mutations. Because IL‑4 induces IL‑10 (Sornasse 
et al., 1996; Levings et al., 2001), and IL‑10 promotes its own 
Figure 10. Impact of monogenic mutations on differentiation of human naive CD4+ T cells. Pathways of human naive CD4+ T cell differentiation in 
vitro and how specific mutations compromise these processes. MSMD, Mendelian susceptibility to mycobacterial disease; IBD, inflammatory bowel disease. 
The corresponding diseases listed occur in individuals with gene mutations that are shown in red type. The genes shown in black type do not result in the 
indicated disease states.
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production (Levings et al., 2001), STAT3 DN mutations may 
abolish Th2‑induced IL‑10 production by impairing auto‑
crine IL‑10 from amplifying its own secretion via IL‑10R/
STAT3 (Fig.  10). However, reduced IL‑10 production by 
IL21R‑deficient naive CD4+ T cells invokes a requirement 
for endogenous IL‑21 in inducing IL‑10 by Th2 conditions. 
Although we did not detect IL‑21 production in the Th2 
culture (Fig. 1), low amounts may be present that function on 
naive CD4+ T cells but are consumed by these cells rendering 
them below the limit of detection. These in vitro findings 
are supported by studies in mice, which demonstrated IL‑21 
induced IL‑10 in CD4+ T cells in an Il21r/Stat3‑dependent 
manner (Spolski et al., 2009). They also recapitulate our recent 
finding that STAT3 DN or IL21R LOF mutations impaired 
IL‑10 secretion by memory CD4+ T cells ex vivo (Ma et al., 
2015), thereby highlighting the importance of this pathway 
for IL‑10 production in vivo. Reductions in IL‑10 produc‑
tion by Th2‑ or Th17‑primed STAT3‑ and IL21R‑deficient 
human naive CD4+ T cells were comparable, indicating IL‑21 
is the predominant STAT3‑activating cytokine responsi‑
ble for regulating IL‑10 secretion by these cells. Early‑onset 
colitis is a hallmark of patients with IL‑10, IL‑10R1, or IL‑
10R2 deficiency (Glocker et al., 2011). Thus, the relevance 
of reduced IL‑10 production by IL‑21R–deficient CD4+ T 
cells is consistent with colitis occurring in some patients with 
IL21/IL21R mutations (Kotlarz et al., 2013, 2014; Salzer et 
al., 2014; Erman et al., 2015). Thus, IL‑21 may prevent in‑
flammation at mucosal surfaces by inducing IL‑10. Whereas 
STAT3 is required downstream of IL‑21R for this effect, re‑
duced IL‑10 production by STAT3 DN CD4+ T cells does 
not cause colitis because these CD4+ T cells are unable to 
mediate IL‑23R/STAT3‑dependent inflammation, a process 
that is dysregulated by IL10R deficiency evidenced by hyper‑
production of Th17 cytokines by IL‑10R–deficient CD4+ T 
cells (Ma et al., 2015; Fig. S1 C). As IL‑10 is also an inducer 
of human B cell differentiation (Moens and Tangye, 2014), 
reduced IL‑10 production by IL‑21R–deficient CD4+ T 
cells could contribute to humoral immune defects caused by 
IL21/IL21R mutations (Kotlarz et al., 2013, 2014; Salzer et 
al., 2014; Erman et al., 2015; Stepensky et al., 2015).
The remarkable parallels between observations made 
from ex vivo analysis of memory CD4+ T cells and those 
from assessment of in vitro differentiation of naive CD4+ T 
cells to defined effector fates underscores the utility and ap‑
plicability of an in vitro approach to dissect human CD4+ T 
cell differentiation. Overlapping defects observed in vitro and 
ex vivo reveal the predominant pathways involved in particu‑
lar biological processes in vivo. From the gene defects studied 
here, IL‑21R/STAT3 signaling is required for Tfh, Th17, and 
IL‑10–secreting cells, yet it represses Th1 responses. STAT3 
also restrains Th2 responses, as shown by increased production 
of IL‑4, IL‑5, and IL‑13 by cTfh cells from STAT3‑deficient 
patients (Fig. S1 D), extending recent findings for Stat3‑defi‑
cient murine Tfh cells (Wu et al., 2015). Similarly, IL12Rβ1/
TYK2 and IFN‑γR/STAT1 signaling are required for Th1 
cells, whereas IL12Rβ1/TYK2, NEMO, and CD40L are also 
required for Th17 induction. There was considerable similar‑
ity in effects of STAT3 DN and STAT1 GOF mutations on 
CD4+ T cell differentiation, including impaired generation 
of Tfh‑ and Th17‑type cells in vitro. This is consistent with 
our recent findings that these mutations comparably altered 
the phenotype and function of cTfh cells and reduced Th17 
cells in vivo (Ma et al., 2015). Collectively, our study provides 
a detailed analysis of molecular requirements for generating 
specialized subsets of human effector CD4+ T cells and reveals 
the value of using experiments of nature to determine these 
pathways. These pathways are not only important for under‑
standing how CD4+ T cells operate but also for identifying 
molecules or pathways that could be targeted to modulate the 
function of Th1, Th2, Th17, Tfh and IL‑10‑producing CD4+ 
T cells in the settings of immunodeficiency or autoimmunity, 
as well as vaccination.
MAT ERI ALS AND MET HODS
Human samples. PBMCs were isolated from healthy controls 
(Australian Red Cross) and PID patients with disease‑causing 
mutations in STAT1, STAT3, IL10R, IL21R, IL21, CD40LG, 
NEMO, ICOS, BTK, IL12RB1, IFN GR1, or TYK2 (Table 
S1; Dorman et al., 2004; Orange et al., 2004; Warnatz et al., 
2006; Holland et al., 2007; Hanson et al., 2008; Avery et al., 
2010; de Beaucoudrey et al., 2010; Ma et al., 2012, 2015; Dee‑
nick et al., 2013; Kotlarz et al., 2013, 2014; Salzer et al., 2014; 
Erman et al., 2015; Kreins et al., 2015; Stepensky et al., 2015; 
Lovell et al., 2016). Human tonsils were obtained from healthy 
donors undergoing routine tonsillectomy (Mater Hospital, 
North Sydney, NSW, Australia). All studies were approved by 
Institutional Human Research Ethics Committees.
Antibodies and reagents. eFluor660‑anti–IL‑21, Alexa Fluor 
488–anti–IL‑10, PerCP‑Cy5.5‑anti–IFN‑γ, FITC‑anti‑
CD45RA, PE‑anti‑ICOS, and anti‑Tbet, and biotin–PD‑1 
were from eBioscience. Alexa Fluor 488–anti‑GATA3, 
Alexa Fluor 647–anti‑CXCR5, anti‑pSTAT4, anti‑pSTAT5, 
anti‑pSTAT6, APC‑anti‑CD10, APC‑Cy7‑anti‑CD4, 
BV605‑anti‑IgG, BV421‑CD40L, BV711‑anti–IL‑2, PE‑anti‑ 
pSTAT1, anti‑RORγt, and Bcl‑6, PE‑Cy7‑anti‑CD25, and 
anti‑CD27, PerCP‑Cy5.5‑anti‑CD127, anti‑pSTAT3, and 
anti‑Tbet, SA‑PerCpCy5.5, and IFN‑γ were obtained from 
BD. Pacific Blue–anti‑CD20 and SA‑BV605 were purchased 
from BioLegend. Recombinant human IL‑12 was purchased 
from R&D Systems. TGF‑β, IL‑1β, IL‑6, IL‑21, and IL‑23 
were obtained from PeproTech. PGE2 was purchased from 
Sigma‑Aldrich. Human IL‑4 and IL‑10 were provided by R. 
de Waal Malefyt (DNAX Research Institute, Palo Alto, CA).
Lymphocyte isolation. For T cells, PBMCs were incubated 
with mAbs to CD4, CD45RA, CCR7, CD127, and CD25. 
Naive CD4+ T cells were isolated by first excluding T reg cells 
(CD25hiCD127lo), and then sorting CD45RA+CCR7+ cells. 
For B cells, tonsil MNCs were incubated with mAbs to 
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CD20, CD27, CD10, and IgG. Naive B cells were isolated by 
sorting CD20+CD10−CD27−IgG− cells.
Analysis of CD4+ T cell differentiation in vitro. Isolated naive 
CD4+ T cells were cultured in 96‑well round bottomed well 
plates (30–40 × 103 cells/well) with T cell activation and expan‑
sion (TAE) beads (anti‑CD2/CD3/CD28; Miltenyi Biotech) 
alone (Th0) or under Th1 (50 ng/ml IL‑12), Th2 (100 U/ml 
IL‑4), or Th17 (2.5 ng/ml TGFβ, 20 ng/ml IL‑1β, 50 ng/ml 
IL‑6, 50 ng/ml IL‑21, 100 ng/ml IL‑23, and 50 ng/ml PGE2) 
polarizing conditions. After 5 d, supernatants were harvested and 
production of IL‑5, IL‑10, IL‑13, IL‑17A, IL‑17F, and IFN‑γ 
determined by CBAs (BD). For cytokine expression, activated 
CD4+ T cells were restimulated with PMA (100 ng/ml)/iono‑
mycin (750 ng/ml) for 6 h, with Brefeldin A (10 µg/ml) added 
after 2 h. Cells were then fixed and expression of intracellular 
cytokines (IL‑2, IL‑10, IL‑21, and IFN‑γ) detected (Ma et al., 
2008, 2012). Due to variability in induction of IL‑21 by IL‑12, 
results are normalized to expression by corresponding control 
naive CD4+ T cells and then averaged for all experiments per‑
formed. In some experiments, naive CD4+ T cells were first la‑
beled with CFSE, and proliferation was determined by assessing 
CFSE dilution (Ma et al., 2008, 2012). For gene expression, 
RNA was extracted, and transcribed into cDNA. Expression of 
TBX21, GATA3, RORC, and BCL6 was determined by qPCR 
and standardized to GAP DH (Ma et al., 2009, 2012). Expression 
of Tbet, GATA3, RORγt, and Bcl‑6 protein was also assessed by 
intracellular staining using a Fix/Perm kit from eBioscience 
(GATA3, RORγt, and Tbet) or following fixing with 2% form‑
aldehyde and permeabilization with saponin (Bcl‑6).
Expression of phospho-STATs. Naive CD4+ T cells were iso‑
lated from healthy donors and preactivated with TAE beads 
for 4–5 d. After this time, the cells were stimulated under Th0, 
Th1, Th17 conditions, or with IL‑10 (100 U/ml), IL‑21 (50 
ng/ml), or IFN‑γ (1,000 U/ml) for 25 min at 37°C. Cells 
were fixed in formaldehyde for 30 min, permeabilized in 90% 
methanol, and then stained with mAbs specific for pSTAT1, 
pSTAT3, pSTAT4, or pSTAT6 (Avery et al., 2010).
T and B cell co-culture assays and Ig determination. Naive 
CD4+ T cells were cultured under Th0, Th1, Th2, or Th17 
conditions for 5 d. After this time, the cells were treated with 
mitomycin C (100 µg/ml; Sigma‑Aldrich), and then co‑cul‑
tured at a 1:1 ratio (50 × 103/200 µl/well) with sort‑purified 
allogeneic naive tonsillar B cells (Ma et al., 2009, 2012). In 
some experiments, exogenous IL‑21 was added to the cul‑
tures. After 7 d, Ig secretion was determined by ELI SA (Avery 
et al., 2010; Ma et al., 2012).
Microarray analysis. Naive CD4+ T cells were isolated from 
PBMCs of healthy controls or from different PID patients by 
sort‑purifying CD4+CD45RA+CD127+CD25lo cells. Memory 
CD4+ T cells from healthy controls were isolated as CD4+C‑
D45RA− cells. RNA was extracted, transcribed to cDNA, and 
then gene expression analysis was determined using Affymetrix 
Human Gene 2.0 or Human Gene 2.1 ST microarray chips. 
Normalization (robust multichip average), log2 transformation 
and probe set summarization were performed for each dataset 
using Bioconductor packages implemented in the R statistical 
computing environment, version 3.1.1. Subsequent processing 
and analyses were performed using GenePattern modules. The 
datasets were merged, quantile normalized, and batch corrected 
using the MergeColumns, NormaliseColumns, and ComBat 
modules. Differential gene expression analysis was assessed using 
LimmaGP. The top 100 differentially expressed genes between 
normal healthy naive and normal healthy memory T cells, as 
determined by LimmaGP analysis, were used to filter the com‑
bined and batch corrected dataset of naive CD4+ T cells from 7 
healthy controls and 19 PID patients, and memory CD4+ T cells 
from three healthy controls. Unsupervised clustering was per‑
formed using NMFConsensus and NMF (Brunet et al., 2004). 
The GEO accession no. for the microarray data is GSE81408.
Statistical analysis. Significant differences were determined 
using Prism (GraphPad Software).
Online supplemental material. Fig. S1 shows the effect of 
monogenic mutations in Th1, Th17, and Th2 cells. Fig. 
S2 depicts CFSE profiles of naive CD4+ T cells obtained 
for healthy donors and PID patients after culture under 
Th1, Th2, or Th17 polarizing conditions. Table S1 lists the 
mutations identified in the indicated genes in each of the 
PID patients included in this study, as well as the nature 
of inheritance, features of each PID. Online supplemental 
material is available at http ://www .jem .org /cgi /content 
/full /jem .20151467 /DC1.
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